Small Cell Lung Cancer Extensive
Amgens Fourth quarter 2009 adjusted earnings per share decreased 1 percent to $ 1.05, Full Year 2009 … Amgen reported adjusted earnings gains adjusted $ 1.05 per share for the fourth quarter of 2009, down 1 percent compared with $ 1.06 for the fourth quarter of 2008. A Adjusted Net income declined 5 percent to $ 1,065 million in the fourth quarter of 2009 compared to $ 1.124 billion in the fourth quarter of 2008.
Small Cell Lung Cancer
